Company intelligence / Profile preview

Ionisos

Civrieux, France
Ownership
Private
Employees
~250
Development stage
Other
01

Overview

Ionisos is a European leader in commercial-scale sterilization services using ionizing radiation (gamma, e-beam, X-ray) and ethylene oxide gas for medical devices, pharmaceuticals, veterinary products, cosmetics, and packaging. The company operates a network of 11 facilities in Europe with strong market positions in France and Spain and is currently expanding its capacity, including new X-ray and e-beam facilities. Ionisos holds certifications including FDA, GMP, and ISO and has a longstanding reputation for regulatory compliance and quality.

Industry
Contract Manufacturing Organization

Beyond the preview

Go deeper on Ionisos.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ionisos.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call